IBD Support (Crohn's & Ulcerative Colitis) protocol

IBD Support (Crohn's & Ulcerative Colitis)

autoimmunemoderate evidence

About this protocol

Inflammatory bowel disease (IBD) affects roughly 3 million Americans across two main forms: Crohn''s disease (can involve any segment of the GI tract, transmural inflammation, often complicated by strictures, fistulas, and surgical resections) and ulcerative colitis (continuous mucosal inflammation limited to the colon, with bloody diarrhea and urgency as hallmark symptoms). This is fundamentally different from IBS (irritable bowel syndrome), which is a functional disorder without structural damage. IBD involves chronic, often progressive intestinal inflammation, ulceration, and sometimes systemic complications (uveitis, arthritis, primary sclerosing cholangitis, increased colorectal cancer risk). The modern treatment revolution is biologic and small-molecule therapy: 5-ASAs (mesalamine for UC), corticosteroids (short-term flare control only), immunomodulators (azathioprine, methotrexate), TNF inhibitors (infliximab/Remicade, adalimumab/Humira), integrin antagonists (vedolizumab/Entyvio), IL-12/23 inhibitors (ustekinumab/Stelara, risankizumab/Skyrizi), and JAK inhibitors (tofacitinib, upadacitinib). These are genuinely transformative — biologic-era outcomes have dramatically reduced surgery rates, steroid dependence, and hospitalizations. This protocol is an ADJUNCTIVE supplement layer for adults with an established IBD diagnosis under gastroenterology care — NOT a substitute for proper medical therapy. It targets: nutrient deficiencies common in IBD due to malabsorption and inflammation (vitamin D, iron, B12), gut barrier support (L-glutamine), and inflammation modulation (omega-3 EPA, curcumin). Trial evidence is strongest for curcumin (Lang 2015 — curcumin + mesalamine outperformed mesalamine alone in UC remission) and vitamin D normalization (Ananthakrishnan 2013 — associated with reduced surgery risk in Crohn''s). CRITICAL: Beware "IBD cure" marketing. There is a substantial ecosystem promising that diet alone, supplements alone, or "leaky gut protocols" can reverse IBD. The honest evidence: supplements + diet measurably help but do NOT replace biologics or immunomodulators in moderate-to-severe disease. Stopping a biologic based on supplement marketing is one of the most reliable ways to lose intestinal tissue.

Where to start

Step 1: See a gastroenterologist — not a naturopath, not a functional medicine clinic, an actual GI. If you have bloody stool, persistent diarrhea, weight loss, abdominal pain, or known IBD that''s flaring, you need endoscopy, biopsies, and proper staging. Untreated IBD destroys intestinal tissue. The wellness-industry framing that "real doctors don''t address root cause" has cost patients colons.

Step 2: Evaluate biologic candidacy. Moderate-to-severe Crohn''s or UC almost always benefits from biologic or immunomodulator therapy. If your GI hasn''t discussed this with you and your disease isn''t well-controlled on 5-ASA alone, ask. The risk-benefit calculus for biologics in moderate-severe IBD strongly favors treatment.

Step 3: Get baseline labs: 25-OH vitamin D (target 40-60 ng/mL), CBC + ferritin + iron studies (iron deficiency anemia is the most common IBD comorbidity), B12 and folate, comprehensive metabolic panel, hsCRP, fecal calprotectin (inflammation marker), and zinc if symptoms suggest deficiency. Anyone with terminal ileum disease or prior ileal resection: B12 status is critical.

Step 4: Start vitamin D3 (higher dose). 2000-5000 IU daily depending on baseline. IBD patients are commonly vitamin D deficient (16-95% across studies per Mouli & Ananthakrishnan 2014), and normalization is associated with reduced disease activity and surgery risk.

Add omega-3 EPA-dominant at 2-3 g daily. Trial evidence specifically in IBD is mixed — Belluzzi 1996 showed enteric-coated fish oil reduced Crohn''s relapse rates, but later larger trials (EPIC-1, EPIC-2) were less impressive. Reasonable as a general anti-inflammatory; not a substitute for medication.

Add L-glutamine at 5-10 g daily. Primary fuel for enterocytes (intestinal lining cells). Trial evidence in IBD mucosal healing is preliminary (Benjamin 2012 showed improved intestinal permeability in Crohn''s); mechanistically supportive.

Add curcumin (phytosome — Meriva, Theracurmin, BCM-95) at 500-1000 mg twice daily. This has the strongest IBD-specific trial evidence: Lang 2015 RCT in UC showed curcumin + mesalamine produced higher clinical remission rates vs mesalamine alone. NF-kB inhibition. Plain curcumin has near-zero bioavailability — the form matters.

B12 considerations if you have terminal ileum disease or prior ileocecal resection: oral B12 absorption may be impaired. Sublingual B12 (2000 mcg daily) is often adequate; intramuscular B12 monthly is the gold standard if labs show deficiency despite oral.

Iron — only if labs confirm deficiency. Oral iron sulfate is often poorly tolerated in active IBD (causes GI symptoms, may worsen inflammation). Lower-irritation forms (iron bisglycinate, iron protein succinylate) tolerate better. IV iron (iron sucrose, ferric carboxymaltose) is preferred when oral fails or in moderate-severe iron deficiency — coordinate with your GI; this is a clinic infusion.

Probiotics (controversial, mention briefly): VSL#3 has modest evidence for adjunctive remission induction in mild-to-moderate UC (Mardini 2014 meta-analysis). Evidence in Crohn''s is poor. Not first-line; not a substitute for medication.

Expect 8-16 weeks before judging response. Track fecal calprotectin (objective inflammation marker), CBC, vitamin D, and clinical symptoms with your GI.

5 nutrients

Start here

Strongest evidence — the foundation of the stack.

Vitamin D3 (Higher Dose for IBD)

2000-5000 IU daily — target 25-OH vitamin D 40-60 ng/mL
morningwith food

IBD patients have markedly higher rates of vitamin D deficiency than the general population (16-95% across cohorts per Mouli & Ananthakrishnan 2014). Ananthakrishnan 2013 showed normalization of 25-OH vitamin D was associated with reduced risk of Crohn''s-related surgery. Mechanism involves immune regulation (T-regulatory cells, dampened Th17), maintenance of intestinal barrier function, and downstream effects on the gut microbiome. Pair with vitamin K2 for cardiovascular safety.[1, 2, 3]

Omega-3 (EPA-dominant)

2-3 g combined EPA+DHA daily (with at least 60% EPA), with breakfast
morningwith food

EPA shifts inflammatory eicosanoid production from pro-inflammatory series-2 (PGE2, LTB4) toward less inflammatory series-3. Belluzzi 1996 NEJM trial showed enteric-coated fish oil reduced Crohn''s relapse rates in maintenance. Later larger trials (EPIC-1/EPIC-2) were less impressive — evidence is mixed but mechanism remains favorable. Reasonable as an anti-inflammatory adjunct; absolutely NOT a substitute for biologics or 5-ASA.[4, 5, 6]

Add if needed

Add these only if the foundation isn't enough.

L-Glutamine

5-10 g daily, mixed in water, away from meals
anytimeempty stomach

L-glutamine is the primary metabolic fuel for enterocytes (intestinal lining cells) and is depleted during active inflammation. Benjamin 2012 RCT in Crohn''s patients showed glutamine + whey protein improved intestinal permeability and mucosal morphology. Evidence is preliminary but mechanistically supportive for barrier function. Best taken away from meals on an empty stomach. Watch for tolerance in active flares — some patients report symptoms.[7, 8, 9]

Curcumin (Phytosome / Bioavailable Form)

500-1000 mg standardized extract twice daily, with meals
morningwith food

Curcumin inhibits NF-kB (master inflammatory transcription factor). Lang 2015 RCT in mild-to-moderate ulcerative colitis showed curcumin (3 g/day) added to mesalamine produced higher clinical remission rates than mesalamine alone — one of the strongest IBD-specific supplement trials. CRITICAL: plain curcumin has near-zero oral bioavailability. Phytosome (Meriva), Theracurmin, or BCM-95 forms have 20-30x the absorption. The form matters enormously.[10, 11, 12]

Experimental

Emerging evidence — try last, only if curious.

Iron (Only If Labs Confirm Deficiency)

25-50 mg elemental iron daily (bisglycinate or protein succinylate forms) IF oral tolerated; otherwise IV iron via GI clinic
morningempty stomach

Iron deficiency anemia is the most common IBD comorbidity (Kaitha 2015) — driven by chronic blood loss in UC, malabsorption, and chronic inflammation. CRITICAL: oral ferrous sulfate is frequently poorly tolerated in active IBD, causes GI symptoms, and may worsen mucosal inflammation. Lower-irritation forms (iron bisglycinate, iron protein succinylate) tolerate better but are still GI-active. Intravenous iron (iron sucrose, ferric carboxymaltose) administered in your GI clinic is the preferred route when oral fails or in moderate-severe deficiency. Do NOT supplement iron without confirmed deficiency (CBC + ferritin + iron studies) — iron overload has its own toxicity.[13, 14, 15]

Warnings

Do not take with: Biologics (infliximab, adalimumab, vedolizumab, ustekinumab, risankizumab) — supplements in this protocol are generally compatible but inform your gastroenterologist of any additions. Immunomodulators (azathioprine, methotrexate, 6-MP) — generally compatible; coordinate timing of NAC/glutathione-related supplements with prescriber. JAK inhibitors (tofacitinib, upadacitinib) — coordinate with GI. Warfarin — vitamin K2 has theoretical interaction; omega-3 and curcumin have mild anti-platelet activity. Calcineurin inhibitors (cyclosporine, tacrolimus) — interactions possible with curcumin. 5-ASA / mesalamine — curcumin synergy is well-tolerated per Lang 2015. Iron supplements should be separated by 2 hours from levothyroxine, fluoroquinolones, and tetracyclines.
Do not take if: You have NOT had a proper IBD diagnosis with endoscopic confirmation. You have an active severe flare (some supplements may worsen — talk to your GI first; iron especially can aggravate active disease). You have a small bowel obstruction or known stricturing Crohn's — high-fiber supplements and L-glutamine boluses are contraindicated. You have severe malabsorption or are on parenteral nutrition — supplement absorption is unreliable; coordinate everything with your medical team. You are pregnant or breastfeeding — high-dose curcumin not well-studied; coordinate with GI and OB. You have an upcoming surgery (discontinue omega-3 and curcumin 1-2 weeks before — anti-platelet activity). You have an active hepatitis flare or severe liver disease. CRITICAL: do NOT stop biologics, immunomodulators, or 5-ASAs based on this protocol. IBD is real, progressive, and warrants real treatment.

Lifestyle improvements

Don''t skip the gastroenterologist

The biggest leverage in IBD management is appropriate medical therapy. Biologics and small molecules have transformed outcomes in the last 20 years — modern biologic-era patients have lower surgery rates, less steroid exposure, and better quality of life than older cohorts could imagine. If your disease isn''t well-controlled or you''re steroid-dependent, escalation of therapy is usually the right answer.

Quit smoking — this is CRITICAL for Crohn''s

Smoking is the single most modifiable Crohn''s disease risk factor and dramatically worsens disease course (more surgeries, more flares, more complications). Smoking cessation produces measurable improvement in Crohn''s within months. (Note: smoking has a paradoxical mild-protective effect in ulcerative colitis — but the cardiovascular and cancer risks vastly outweigh any colonic benefit, so quitting is still the right move for UC patients.)

Mediterranean dietary pattern

The most-evidenced dietary pattern for IBD adjunctive support. Emphasizes olive oil, fish, vegetables, legumes, fruits, nuts, whole grains, with limited red meat and processed food. Anti-inflammatory and well-tolerated by most IBD patients in remission. The 2020 IOIBD diet recommendations endorse Mediterranean-style eating as a reasonable baseline.

Crohn''s Disease Exclusion Diet (CDED) and Specific Carbohydrate Diet (SCD)

CDED + partial enteral nutrition has trial evidence (Levine 2019, Gastroenterology) for inducing remission in pediatric Crohn''s with effects comparable to exclusive enteral nutrition. SCD has anecdotal and small-trial support but is restrictive — work with a dietitian familiar with IBD before attempting. Do NOT use these diets as a substitute for medication in moderate-severe disease; they''re adjunctive at best.

Identify YOUR food triggers individually

Common triggers vary by patient: lactose, FODMAPs, raw vegetables, nuts/seeds (especially in stricturing Crohn''s), spicy food, alcohol, carbonated beverages, caffeine. A symptom-and-food journal under dietitian guidance is more useful than internet "IBD diet" lists. Stricturing Crohn''s especially requires a low-residue / low-fiber approach during symptomatic periods.

Stress management

Stress is a documented IBD flare trigger via the gut-brain axis. CBT, mindfulness-based interventions, structured stress reduction, and addressing chronic stressors directly produce measurable disease activity improvement. The Rome Foundation and AGA both endorse psychological intervention as adjunctive IBD care.

Mental health support is part of IBD care

Depression and anxiety are 2-3x more common in IBD than the general population. Treating mental health is not optional — untreated psychiatric comorbidity worsens disease outcomes, adherence, and quality of life. SSRIs are generally safe in IBD; gut-directed hypnotherapy and CBT have trial support.

Surgical considerations

If you have a prior ileal or ileocecal resection, your supplement strategy changes: B12 needs are higher (consider sublingual or intramuscular), bile-acid malabsorption may produce diarrhea (cholestyramine helps), and fat-soluble vitamins (A, D, E, K) require monitoring. Coordinate with your GI and dietitian on a resection-aware nutrition plan.

Cancer surveillance — don''t skip it

Long-standing IBD (especially extensive UC and Crohn''s colitis) elevates colorectal cancer risk. Surveillance colonoscopy every 1-3 years depending on duration and extent is standard. PSC overlap requires additional cholangiocarcinoma surveillance. This is non-negotiable preventive care.

Bone health from chronic steroid exposure

Repeated corticosteroid courses cause osteopenia and osteoporosis. DEXA scans every 2 years for anyone with significant cumulative steroid exposure. Vitamin D + K2 + calcium-adequate diet + weight-bearing exercise + minimize steroids whenever biologics or immunomodulators can replace them.

Gut-aware exercise

Regular moderate exercise reduces systemic inflammation and is safe in IBD remission. During flares, scale to what''s tolerable. Avoid high-impact activity around active perianal Crohn''s. Walking and resistance training are well-tolerated baselines.

Beware "IBD cure" marketing

There''s a substantial wellness-industry ecosystem promising leaky gut protocols, microbiome resets, IgG food testing, and "natural healing" can cure IBD. The honest evidence: lifestyle and supplements measurably help symptoms and disease activity but do NOT replace biologics in moderate-severe disease. Patients who stopped biologics based on supplement marketing have lost colons. Don''t fall for it.

Patient organizations

The Crohn''s & Colitis Foundation (CCF) offers evidence-based resources, clinical trial matching, peer support, and advocacy. Use them — they''re the best source for current treatment standards and patient-community knowledge.

References

  1. Vitamin D — supplement research overviewExamine.com link
  2. Mouli VP, Ananthakrishnan AN. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014;39(2):125-136.PubMed link
  3. Ananthakrishnan AN, et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn''s disease. Inflamm Bowel Dis. 2013;19(9):1921-1927.PubMed link
  4. Fish oil — supplement research overviewExamine.com link
  5. Belluzzi A, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn''s disease. N Engl J Med. 1996;334(24):1557-1560.PubMed link
  6. Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017;45(5):1105-1115.PubMed link
  7. Glutamine — supplement research overviewExamine.com link
  8. Benjamin J, et al. Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn''s disease: a randomized controlled trial. Dig Dis Sci. 2012;57(4):1000-1012.PubMed link
  9. Coëffier M, Marion-Letellier R, Déchelotte P. Potential for amino acids supplementation during inflammatory bowel diseases. Inflamm Bowel Dis. 2010;16(3):518-524.PubMed link
  10. Curcumin — supplement research overviewExamine.com link
  11. Lang A, et al. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2015;13(8):1444-1449.e1.PubMed link
  12. Hewlings SJ, Kalman DS. Curcumin: A Review of Its Effects on Human Health. Foods. 2017;6(10):92.PubMed link
  13. Iron — supplement research overviewExamine.com link
  14. Kaitha S, Bashir M, Ali T. Iron deficiency anemia in inflammatory bowel disease. World J Gastrointest Pathophysiol. 2015;6(3):62-72.PubMed link
  15. Filippi J, et al. Nutritional deficiencies in patients with Crohn''s disease in remission. Inflamm Bowel Dis. 2006;12(3):185-191.PubMed link
  16. Levine A, et al. Crohn''s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. Gastroenterology. 2019;157(2):440-450.e8.PubMed link
  17. Mardini HE, Grigorian AY. Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: a meta-analysis. Inflamm Bowel Dis. 2014;20(9):1562-1567.PubMed link

Track this protocol in Pilora

Add these supplements to your shelf, get smart dose reminders, and check for interactions — all in the Pilora iPhone app.

Coming to App Store

Disclaimer: These statements have not been evaluated by the FDA. This protocol is educational, not a substitute for personalized medical advice. Talk to your doctor before starting any new supplement regimen — especially if you're pregnant, breastfeeding, on medications, or managing a chronic condition. Last updated 5/20/2026.